Alain Fournier
#144,739
Most Influential Person Now
Alain Fournier's AcademicInfluence.com Rankings
Alain Fournierbiology Degrees
Biology
#10446
World Rank
#13776
Historical Rank
Endocrinology
#138
World Rank
#150
Historical Rank
Neuroscience
#1615
World Rank
#1666
Historical Rank
Biochemistry
#1647
World Rank
#1782
Historical Rank
Download Badge
Biology
Alain Fournier's Degrees
- PhD Neuroscience Université Paris Cité
Why Is Alain Fournier Influential?
(Suggest an Edit or Addition)Alain Fournier's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. (2000) (1124)
- Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery (2009) (952)
- Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues (1992) (376)
- hCGRP8-37, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and periphery. (1990) (333)
- Pulmonary clearance of circulating endothelin-1 in dogs in vivo: exclusive role of ETB receptors. (1996) (314)
- The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration. (2003) (243)
- Structure-activity profile of calcitonin gene-related peptide in peripheral and brain tissues. Evidence for receptor multiplicity. (1989) (240)
- Comparative characterization and autoradiographic distribution of neuropeptide Y receptor subtypes in the rat brain (1993) (207)
- Presynaptic inhibition by neuropeptide Y in rat hippocampal slice in vitro is mediated by a Y2 receptor (1991) (195)
- PACAP protects cerebellar granule neurons against oxidative stress‐induced apoptosis (2002) (187)
- Pituitary adenylate cyclase-activating polypeptide promotes cell survival and neurite outgrowth in rat cerebellar neuroblasts (1997) (187)
- The Neuropeptide Y (NPY) Y1 Receptor Subtype Mediates NPY-induced Antidepressant-like Activity in the Mouse Forced Swimming Test (2002) (186)
- Pituitary Adenylate Cyclase-Activating Polypeptide (2003) (183)
- Characterization of CGRP1 and CGRP2 Receptor Subtypes a (1992) (179)
- Synthesis, biological activity and conformational analysis of cyclic GRF analogs. (2009) (166)
- Identification of nonpeptidic urotensin II receptor antagonists by virtual screening based on a pharmacophore model derived from structure-activity relationships and nuclear magnetic resonance studies on urotensin II. (2002) (165)
- Neurotrophic activity of pituitary adenylate cyclase-activating polypeptide on rat cerebellar cortex during development. (1999) (162)
- Autoradiographic distribution of [125I]Leu31,Pro34]PYY and [125I]PYY3–36 binding sites in the rat brain evaluated with two newly developed Y1 and Y2 receptor radioligands (1996) (159)
- Pituitary adenylate cyclase-activating polypeptide protects rat cerebellar granule neurons against ethanol-induced apoptotic cell death (2002) (153)
- Expression and Characterization of the Neuropeptide Y Y5 Receptor Subtype in the Rat Brain (1998) (151)
- Monoclonal antibodies to rabbit progesterone receptor: crossreaction with other mammalian progesterone receptors. (1983) (140)
- Stable Multicopy Vectors for High–Level Secretion of Recombinant Human Serum Albumin by Kluyveromyces Yeasts (1991) (137)
- Structure-function analysis of stimulation of food intake by neuropeptide Y: Effects of receptor agonists (1991) (137)
- The neuroprotective effect of pituitary adenylate cyclase-activating polypeptide on cerebellar granule cells is mediated through inhibition of the CED3-related cysteine protease caspase-3/CPP32. (2000) (131)
- Selenoprotein T is a PACAP‐regulated gene involved in intracellular Ca2+ mobilization and neuroendocrine secretion (2008) (130)
- Characterization of neuropeptide Y binding sites in rat brain membrane preparations using [125I][Leu31,Pro34]peptide YY and [125I]peptide YY3-36 as selective Y1 and Y2 radioligands. (1995) (123)
- The neurotrophic effects of PACAP in PC12 cells: control by multiple transduction pathways (2006) (118)
- Differential distribution of neuropeptide Y1 and Y2 receptors in the rat brain. (1990) (112)
- Acute pro‐inflammatory actions of endothelin‐1 in the guinea‐pig lung: involvement of ETA and ETB receptors (1995) (112)
- Novel stable PACAP analogs with potent activity towards the PAC1 receptor (2008) (112)
- High-level secretion of correctly processed recombinant human interleukin-1 beta in Kluyveromyces lactis. (1991) (110)
- One-step immunoaffinity purification of active progesterone receptor. Further evidence in favor of the existence of a single steroid binding subunit. (1985) (107)
- Opposite regulation of the mitochondrial apoptotic pathway by C2‐ceramide and PACAP through a MAP‐kinase‐dependent mechanism in cerebellar granule cells (2004) (103)
- The S. Cerevisiae HAP Complex, a Key Regulator of Mitochondrial Function, Coordinates Nuclear and Mitochondrial Gene Expression (2003) (103)
- Comparative distribution of pituitary adenylate cyclase‐activating polypeptide (PACAP) binding sites and PACAP receptor mRNAs in the rat brain during development (2000) (101)
- Occurrence of two somatostatin variants in the frog brain: characterization of the cDNAs, distribution of the mRNAs, and receptor-binding affinities of the peptides. (1996) (101)
- Protective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) against apoptosis. (2011) (100)
- Involvement of the Y-1 receptor subtype in the regulation of luteinizing hormone secretion by neuropeptide Y in rats. (1992) (98)
- Pituitary Adenylate Cyclase-Activating Polypeptide Inhibits Food Intake in Mice Through Activation of the Hypothalamic Melanocortin System (2009) (98)
- Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on corticotropin-releasing hormone (CRH) gene expression in the rat hypothalamic paraventricular nucleus (1997) (96)
- Urotensin II, from fish to human (2010) (96)
- Pituitary adenylate cyclase‐activating polypeptide prevents C2‐ceramide‐induced apoptosis of cerebellar granule cells (2003) (96)
- Rat α‐Synuclein Interacts with Tat Binding Protein 1, a Component of the 26S Proteasomal Complex (2000) (95)
- Inhibitory Effect of PACAP on Caspase Activity in Neuronal Apoptosis: A Better Understanding Towards Therapeutic Applications in Neurodegenerative Diseases (2008) (93)
- Characterization of melanotropin-release-inhibiting factor (melanostatin) from frog brain: homology with human neuropeptide Y. (1991) (93)
- Localization and characterization of PACAP receptors in the rat cerebellum during development: Evidence for a stimulatory effect of PACAP on immature cerebellar granule cells (1993) (90)
- Neuropeptide-Y in the trout brain and pituitary: localization, characterization, and action on gonadotropin release. (1991) (89)
- Immunohistochemical distribution and biological activity of pituitary adenylate cyclase‐activating polypeptide (PACAP) in the central nervous system of the frog Rana ridibunda (1992) (85)
- Neuropeptide Y inhibits Ca2+ influx into cultured dorsal root ganglion neurones of the rat via a Y2 receptor (1991) (84)
- Distribution, Characterization, and Growth Hormone-Releasing Activity of Pituitary Adenylate Cyclase-Activating Polypeptide in the European Eel, Anguilla anguilla* * This work was supported by grants from INSERM U-413, the Conseil Supérieur de la Pêche, and the Conseil Régional de Haute-Normandie (1998) (81)
- Mapping of hypothalamic sites involved in the effects of NPY on body temperature and food intake (1995) (79)
- Applications of BOP reagent in solid phase synthesis. Advantages of BOP reagent for difficult couplings exemplified by a synthesis of [Ala 15]-GRF(1-29)-NH2. (2009) (78)
- Enhancement by endothelin‐1 of microvascular permeability via the activation of ETA receptors (1993) (78)
- Neurobehavioral profile of neuropeptide Y (1991) (76)
- Vascular responses to endothelin‐1 following inhibition of nitric oxide synthesis in the conscious rat (1993) (76)
- Comparative affinities and antagonistic potencies of various human calcitonin gene-related peptide fragments on calcitonin gene-related peptide receptors in brain and periphery. (1991) (76)
- Pituitary Adenylate Cyclase‐Activating Polypeptide (PACAP) Stimulates Adenylyl Cyclase and Phospholipase C Activity in Rat Cerebellar Neuroblasts (1995) (75)
- Pituitary adenylate cyclase-activating polypeptide: focus on structure-activity relationships of a neuroprotective Peptide. (2009) (75)
- International Union of Basic and Clinical Pharmacology. XCII. Urotensin II, Urotensin II–Related Peptide, and Their Receptor: From Structure to Function (2015) (74)
- Structural requirements for VIP interaction with specific receptors in human and rat intestinal membranes: effect of nine partial sequences. (1984) (73)
- Autoradiographic distribution and receptor binding profile of [125I]Bolton Hunter-rat amylin binding sites in the rat brain. (1994) (73)
- Molecular and conformational determinants of pituitary adenylate cyclase-activating polypeptide (PACAP) for activation of the PAC1 receptor. (2009) (72)
- Agonist‐ and antagonist‐induced sequestration/internalization of neuropeptide Y Y1 receptors in HEK293 cells (2003) (72)
- Pituitary adenylate cyclase-activating polypeptide prevents the effects of ceramides on migration, neurite outgrowth, and cytoskeleton remodeling. (2005) (71)
- Neurotrophic effects of PACAP in the cerebellar cortex (2007) (70)
- Role of serotonin (5-HT) in the antidepressant-like properties of neuropeptide Y (NPY) in the mouse forced swim test (2005) (69)
- Structure–activity studies on substance P (1979) (69)
- Peptide YY derivatives as selective neuropeptide Y/peptide YY Y1 and Y2 agonists devoided of activity for the Y3 receptor sub-type. (1994) (68)
- Potent and selective tools to investigate neuropeptide Y receptors in the central and peripheral nervous systems: BIB03304 (Y1) and CGP71683A (Y5). (2000) (67)
- PACAP inhibits delayed rectifier potassium current via a cAMP/PKA transduction pathway: evidence for the involvement of IK in the anti‐apoptotic action of PACAP (2004) (67)
- Role of PACAP and VIP in astroglial functions (2007) (66)
- Frog vasoactive intestinal polypeptide and galanin: primary structures and effects on pituitary adenylate cyclase. (1995) (66)
- Distribution, characterization, and growth hormone-releasing activity of pituitary adenylate cyclase-activating polypeptide in the European eel, Anguilla anguilla. (1998) (65)
- Adaptation of iso-tRNA concentration to mRNA codon frequency in the eukaryote cell. (1979) (65)
- Characterization and localization of vasoactive intestinal peptide receptors in the rat lung. (1984) (64)
- Pituitary adenylate cyclase-activating polypeptide stimulates both adrenocortical cells and chromaffin cells in the frog adrenal gland. (1994) (64)
- Pharmacological characterization of CGRP1 receptor subtype in the vascular system of the rat: Studies with hCGRP fragments and analogs (1990) (63)
- Ontogeny of pituitary adenylate cyclase-activating polypeptide (PACAP) receptors in the rat cerebellum: a quantitative autoradiographic study. (1994) (63)
- PACAP and a novel stable analog protect rat brain from ischemia: Insight into the mechanisms of action (2011) (63)
- Functional and Binding Characterizations of Urotensin II-Related Peptides in Human and Rat Urotensin II-Receptor Assay (2003) (62)
- Effects of NPY and NPY2–36 on body temperature and food intake following administration into hypothalamic nuclei (1995) (61)
- Endothelin-1 enhances vascular permeability in conscious rats: role of thromboxane A2. (1992) (60)
- Pituitary adenylate cyclase‐activating polypeptide (PACAP) stimulates endozepine release from cultured rat astrocytes via a PKA‐dependent mechanism (2003) (60)
- PACAP and NGF regulate common and distinct traits of the sympathoadrenal lineage: effects on electrical properties, gene markers and transcription factors in differentiating PC12 cells (2003) (59)
- Microarray and suppression subtractive hybridization analyses of gene expression in pheochromocytoma cells reveal pleiotropic effects of pituitary adenylate cyclase-activating polypeptide on cell proliferation, survival, and adhesion. (2003) (59)
- Quantitative autoradiographic distribution of [125i]bolton-hunter neuropeptide y receptor binding sites in rat brain. comparison with [125i]peptide yy receptor sites (1990) (59)
- Pituitary adenylate cyclase‐activating polypeptide protects astroglial cells against oxidative stress‐induced apoptosis (2011) (58)
- Regulation of proopiomelanocortin gene expression by neuropeptide Y in the rat arcuate nucleus (1995) (57)
- Presence of neuropeptide Y and the Y1 receptor in the plasma membrane and nuclear envelope of human endocardial endothelial cells: modulation of intracellular calcium. (2003) (57)
- Neuropeptide Y potentiates the N-methyl-D-aspartate response in the CA3 dorsal hippocampus. II. Involvement of a subtype of sigma receptor. (1992) (56)
- Secretion of active anti-Ras single-chain Fv antibody by the yeasts Yarrowia lipolytica and Kluyveromyces lactis. (2002) (53)
- Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on gonadotropin-releasing hormone and somatostatin gene expression in the rat brain. (1996) (53)
- Characterization of ETB receptors mediating contractions induced by endothelin‐1 or IRL 1620 in guinea‐pig isolated airways: effects of BQ‐123, FR139317 or PD 145065 (1994) (52)
- Calcitonin gene-related peptide (hCGRPα) binding sites in the nucleus accumbens. Atypical structural requirements and marked phylogenic differences (1991) (51)
- Structure–activity relationships of urotensin II and URP (2008) (50)
- Stimulation of the Sympathetic Perimesenteric Arterial Nerves Releases Neuropeptide Y Potentiating the Vasomotor Activity of Noradrenaline: Involvement of Neuropeptide Y‐Y1 Receptors (1997) (50)
- Localization, characterization and activity of pituitary adenylate cyclase-activating polypeptide in the frog adrenal gland. (1993) (49)
- Characterization of neuropeptide Y receptor subtypes in the normal human brain, including the hypothalamus (1997) (48)
- In vivo structure activity study supports the existence of heterogeneous neuropeptide Y receptors (1991) (46)
- Isatuximab Acts Through Fc-Dependent, Independent, and Direct Pathways to Kill Multiple Myeloma Cells (2020) (46)
- Involvement of ETA receptors in the facilitation by endothelin‐1 of non‐adrenergic non‐cholinergic transmission in the rat urinary bladder (1994) (46)
- Distribution of Peripherally Injected Peptide YY ([125I] PYY (3–36)) and Pancreatic Polypeptide ([125I] hPP) in the CNS: Enrichment in the Area Postrema (2007) (46)
- Quantitative data on the Bombyx mori L. silkworm: a review. (1979) (45)
- Pituitary adenylate cyclase-activating polypeptide stimulates secretoneurin release and secretogranin II gene transcription in bovine adrenochromaffin cells through multiple signaling pathways and increased binding of pre-existing activator protein-1-like transcription factors. (2001) (45)
- Regulation of cardiac nitric oxide signaling by nuclear β-adrenergic and endothelin receptors. (2013) (45)
- Role of neuropeptide Y Y1 and Y2 receptors on behavioral despair in a rat model of depression with co-morbid anxiety (2012) (45)
- Binding profile of a selective calcitonin gene-related peptide (CGRP) receptor antagonist ligand, [125I-Tyr]hCGRP8-37, in rat brain and peripheral tissues. (1994) (44)
- Chronically elevated endothelin levels reduce pulmonary vascular reactivity to nitric oxide. (2005) (44)
- Endothelin-1 enhances vascular permeability in the rat heart through the ETA receptor. (1992) (44)
- Neuropeptide Y Receptors: Autoradiographic Distribution in the Brain and Structure‐Activity Relationships a (1990) (44)
- Characterizations of a synthetic pituitary adenylate cyclase-activating polypeptide analog displaying potent neuroprotective activity and reduced in vivo cardiovascular side effects in a Parkinson's disease model (2016) (43)
- Neuropeptide Y potentiates selectively the N-methyl-D-aspartate response in the rat CA3 dorsal hippocampus. I. Involvement of an atypical neuropeptide Y receptor. (1992) (43)
- Rat alpha-synuclein interacts with Tat binding protein 1, a component of the 26S proteasomal complex. (2000) (43)
- Evidence for in vivo interactions between neuropeptide Y-related peptides and sigma receptors in the mouse hippocampal formation (1993) (43)
- PACAP and C2‐ceramide generate different AP‐1 complexes through a MAP‐kinase‐dependent pathway: involvement of c‐Fos in PACAP‐induced Bcl‐2 expression (2006) (42)
- Structure‐Activity Analysis of CGRP's Neurobehavioral Effects a (1992) (42)
- Tissue-Specific Regulation of Fat Cell Lipolysis by NPY in 6-OHDA-Treated Rats (1997) (42)
- Novel Splice Variants of Type I Pituitary Adenylate Cyclase-Activating Polypeptide Receptor in Frog Exhibit Altered Adenylate Cyclase Stimulation and Differential Relative Abundance. (2002) (42)
- Evaluation of truncated neuropeptide Y analogues with modifications of the tyrosine residue in position 1 on Y1, Y2 and Y3 receptor sub-types. (1993) (41)
- Strategies to convert PACAP from a hypophysiotropic neurohormone into a neuroprotective drug. (2011) (41)
- Intracrine endothelin signaling evokes IP3-dependent increases in nucleoplasmic Ca²⁺ in adult cardiac myocytes. (2013) (41)
- Distribution and functional characterization of pituitary adenylate cyclase–activating polypeptide receptors in the brain of non-human primates (2009) (40)
- Structure-activity study of hCGRP8-37, a calcitonin gene-related peptide receptor antagonist. (1992) (40)
- Peroxiredoxin 2 is Involved in the Neuroprotective Effects of PACAP in Cultured Cerebellar Granule Neurons (2008) (40)
- Synthesis, conformational studies and biological activities of VIP and related fragments (1984) (40)
- Design and in vitro characterization of PAC1/VPAC1-selective agonists with potent neuroprotective effects. (2011) (40)
- Neuroanatomical and Physiological Evidence for the Involvement of Pituitary Adenylate Cyclase‐Activating Polypeptide in the Regulation of the Distal Lobe of the Frog Pituitary (1993) (40)
- Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226. (1999) (40)
- The Neurotrophic Activity of PACAP on Rat Cerebellar Granule Cells Is Associated with Activation of the Protein Kinase A Pathway and c‐fos Gene Expression a, (1998) (39)
- A potent and selective CGRP2 agonist, ys(Et)2,7]hCGRPα: comparison in prototypical CGRP1 and CGRP2 in vitro ioassays (1997) (39)
- Extracellular signal‐regulated kinase plays an essential role in endothelin‐1‐induced homotypic adhesion of human neutrophil granulocytes (2002) (39)
- Intracellular Angiotensin‐II Interacts With Nuclear Angiotensin Receptors in Cardiac Fibroblasts and Regulates RNA Synthesis, Cell Proliferation, and Collagen Secretion (2017) (39)
- PAC1 Receptor Activation by PACAP-38 Mediates Ca2+ Release from a cAMP-dependent Pool in Human Fetal Adrenal Gland Chromaffin Cells* (2003) (38)
- Biochemical and pharmacological characterization of nuclear urotensin‐II binding sites in rat heart (2012) (38)
- Characterization of Murine Coronavirus Neutralization Epitopes with Phage-Displayed Peptides (2000) (37)
- A Cloned Frog Vasoactive Intestinal Polypeptide/ Pituitary Adenylate Cyclase-Activating Polypeptide Receptor Exhibits Pharmacological and Tissue Distribution Characteristics of Both VPAC1 and VPAC2 Receptors in Mammals. (1999) (37)
- Adrenomedullin receptor binding sites in rat brain and peripheral tissues. (2003) (37)
- Structural study of the N-terminal segment of neuropeptide tyrosine. (1990) (37)
- Characterization of a binding site for angiotensin IV on bovine aortic endothelial cells. (1995) (36)
- The Neuropeptide Pituitary Adenylate Cyclase‐Activating Polypeptide Exerts Anti‐Apoptotic and Differentiating Effects during Neurogenesis: Focus on Cerebellar Granule Neurones and Embryonic Stem Cells (2007) (36)
- Neuroprotective Effects of PACAP Against Ethanol-Induced Toxicity in the Developing Rat Cerebellum (2011) (36)
- Nonadrenergic and noncholinergic arterial dilatation and venoconstriction are mediated by calcitonin gene-related peptide1 and neurokinin-1 receptors, respectively, in the mesenteric vasculature of the rat after perivascular nerve stimulation. (1992) (35)
- Effect of accelerated aging on protein synthesis in two legume seeds (1988) (35)
- Comparative structural requirements of brain neuropeptide Y binding sites and vas deferens neuropeptide Y receptors. (1990) (35)
- Role of neuropeptide Y in the regulation of gonadotropin-releasing hormone gene expression in the rat preoptic area. (1994) (35)
- Characterization of receptors mediating vascular responses to endothelin‐1 in the conscious rat (1994) (34)
- PACAP Acts as a Neurotrophic Factor During Histogenesis of the Rat Cerebellar Cortex (2000) (34)
- Discovery of new antagonists aimed at discriminating UII and URP‐mediated biological activities: insight into UII and URP receptor activation (2013) (33)
- Effect of centrally administered neuropeptide Y on hypothalamic and hypophyseal proopiomelanocortin-derived peptides in the rat (1995) (33)
- Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Enhances Hippocampal Synaptic Plasticity and Improves Memory Performance in Huntington’s Disease (2018) (33)
- The H295R human adrenocortical cell line contains functional atrial natriuretic peptide receptors that inhibit aldosterone biosynthesis (1996) (33)
- Localization and characterization of pituitary adenylate cyclase‐activating polypeptide receptors in the human cerebellum during development (2006) (32)
- Synthesis of peptides by the solid-phase method. 7. Substance P and analogues. (1982) (32)
- Neuropeptide tyrosine in the brain of the African lungfish, Protopterus annectens: Immunohistochemical localization and biochemical characterization (1995) (32)
- Endothelin‐1‐induced myocardial ischaemia and oedema in the rat: involvement of the ETA receptor, platelet‐activating factor and thromboxane A2 (1994) (32)
- Pituitary adenylate cyclase‐activating polypeptide and its receptors in amphibians (2001) (31)
- Neuropeptide Y Y2 receptors in hypothalamic neuroendocrine areas are up-regulated by estradiol and decreased by progesterone cotreatment in the ovariectomized rat. (1996) (31)
- Decreased levels of neuropeptide Y5 receptor binding sites in two experimental models of epilepsy (2000) (31)
- A specific binding site recognizing a fragment of angiotensin II in bovine adrenal cortex membranes. (1994) (30)
- Characterization of endothelin (ET) receptors in the isolated gall bladder of the guinea‐pig: evidence for an additional ET receptor subtype (1994) (30)
- Neuropeptide Y Inhibits the Biosynthesis of Sulfated Neurosteroids in the Hypothalamus through Activation of Y1 Receptors. (2002) (30)
- Receptor-independent cellular uptake of pituitary adenylate cyclase-activating polypeptide. (2012) (30)
- PACAP prevents toxicity induced by cisplatin in rat and primate neurons but not in proliferating ovary cells: Involvement of the mitochondrial apoptotic pathway (2008) (30)
- Endothelins as local activators of adrenocortical cells. (2004) (29)
- Characterization of human beta-interferon-binding sites on human cells. (1985) (28)
- Upregulation of adrenomedullin in the spinal cord and dorsal root ganglia in the early phase of CFA-induced inflammation in rats (2009) (28)
- Biological and Structural Analysis of Truncated Analogs of PACAP27 (2008) (27)
- Role of neuropeptide Y in the regulation of tyrosine hydroxylase gene expression in rat adrenal glands. (1995) (27)
- Bronchoconstrictor action of neuropeptide Y (NPY) in isolated guinea pig airways (1989) (27)
- Bronchoprotector properties of calcitonin gene-related peptide in guinea pig and human airways. Effect of pulmonary inflammation. (1999) (27)
- Synthesis of peptides by the solid-phase method. V. Substance P and analogs. (1980) (27)
- Design and characterization of novel cell-penetrating peptides from pituitary adenylate cyclase-activating polypeptide. (2012) (26)
- Localization, identification, and action of calcitonin gene-related peptide in the frog adrenal gland. (1994) (26)
- Localization, characterization, and second messenger coupling of pituitary adenylate cyclase-activating polypeptide receptors in the fetal human adrenal gland during the second trimester of gestation. (1998) (26)
- Neuropeptide Y inhibits α-MSH release from rat hypothalamic slices through a pertussis toxin-sensitive G protein (1992) (26)
- The primary structure of the 3-phosphoglycerate kinase (PGK) gene from Kluyveromyces lactis. (1990) (26)
- Expression of alcohol dehydrogenase in rice embryos under anoxia (1986) (26)
- Selectivity for binding of peptide analogs to vascular receptors for vasoactive intestinal peptide. (1990) (25)
- Update on the urotensinergic system: new trends in receptor localization, activation, and drug design (2012) (25)
- Structural studies on 26RFa, a novel human RFamide-related peptide with orexigenic activity (2005) (25)
- Endothelin reduces microvascular blood flow by acting on and venules of the hamster cheek pouch (1990) (25)
- C‐reactive protein‐derived peptide 201–206 inhibits neutrophil adhesion to endothelial cells and platelets through CD32 (2011) (25)
- Urocontrin, a novel UT receptor ligand with a unique pharmacological profile. (2012) (25)
- Involvement of endogenous antioxidant systems in the protective activity of pituitary adenylate cyclase‐activating polypeptide against hydrogen peroxide‐induced oxidative damages in cultured rat astrocytes (2016) (25)
- BOP reagent for the coupling of pGlu and Boc-His(Tos) in solid phase peptide synthesis. (1990) (25)
- The dog saphenous vein: a sensitive and selective preparation for the Y2 receptor of neuropeptide Y. (1997) (25)
- The rabbit ileum: a sensitive and selective preparation for the neuropeptide Y Y5 receptor. (1997) (25)
- Characterization of urotensin-II receptor structural domains involved in the recognition of U-II, URP, and urantide. (2006) (24)
- Development of photolabile caged analogs of endothelin-1 (2007) (24)
- Secondary conformational conversion is involved in glycosaminoglycans‐mediated cellular uptake of the cationic cell‐penetrating peptide PACAP (2014) (24)
- Conformational Analysis of Vasoactive Intestinal Peptide and Related Fragments a (1988) (24)
- Age and castration modulate the inhibitory action of neuropeptide Y on neurotransmission in the rat vas deferens. (1991) (23)
- VIP and PACAP stimulate TSH release from the bullfrog pituitary (2007) (23)
- Neuropeptide Y Inhibits Spontaneous α-Melanocyte-Stimulating Hormone (α-MSH) Release via a Y5 Receptor and Suppresses Thyrotropin-Releasing Hormone-Induced α-MSH Secretion via a Y1 Receptor in Frog Melanotrope Cells. (2002) (23)
- Effectiveness of the suzuki-miyaura cross-coupling reaction for solid-phase peptide modification. (2008) (23)
- Purification of a galanin receptor from pig brain. (1993) (23)
- Localization, identification, and action of galanin in the frog adrenal gland. (1996) (22)
- The rabbit saphenous vein: a tissue preparation specifically enriched in NPY-Y1 receptor subtype (1993) (22)
- Characterization and effects on cAMP accumulation of adrenomedullin and calcitonin gene‐related peptide (CGRP) receptors in dissociated rat spinal cord cell culture (2006) (21)
- BODIPY®‐conjugated neuropeptide Y ligands: new fluorescent tools to tag Y1, Y2, Y4 and Y5 receptor subtypes (2005) (21)
- Identification by photoaffinity labeling of the extracellular N-terminal domain of PAC1 receptor as the major binding site for PACAP. (2011) (21)
- Characterization of the receptor mediating the effect of calcitonin gene-related peptide in the frog adrenal gland. (1996) (21)
- Mouse aorta: a preparation highly sensitive to the vasodilatory action of CGRP. (1997) (21)
- Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1–7), NPY(19–23), Ala31, Aib32, Gln34]hPP (2004) (21)
- Characterization and localization of pituitary adenylate cyclase–activating polypeptide (PACAP) binding sites in the brain of the frog Rana ridibunda (1999) (21)
- Turnover of transfer RNA species during development of the posterior silkgland of Bombyx mori L. (1976) (20)
- Effect of Pituitary Adenylate Cyclase‐Activating Polypeptide (PACAP) on Tyrosine Hydroxylase Gene Expression in the Rat Adrenal Medulla (1998) (20)
- Ontogeny of PACAP and PACAP Receptors in the Rat Brain: Role of PACAP in the Cerebellum during Development a (1996) (20)
- Effects of the ETA/ETB receptor antagonist, bosentan on endothelin‐1‐induced myocardial ischaemia and oedema in the rat (1995) (19)
- Characterization of endothelin receptors mediating mechanical responses to the endothelins in the isolated stomach strip of the rat. (1995) (19)
- Origin of Secretin Receptor Precedes the Advent of Tetrapoda: Evidence on the Separated Origins of Secretin and Orexin (2011) (19)
- Occurrence and Effect of PACAP in the Human Fetal Adrenal Gland (2000) (19)
- Evidence for the Existence of an Additional Class of Neuropeptide Y Receptor Sites in Rat Brain (2005) (19)
- The Expression of Multiple Connexins Throughout Spermatogenesis in the Rainbow Trout Testis Suggests a Role for Complex Intercellular Communication1 (2007) (19)
- Cortical‐layer‐specific effects of PACAP and tPA on interneuron migration during post‐natal development of the cerebellum (2014) (19)
- PACAP Stimulates Biosynthesis and Release of Endozepines from Rat Astrocytes (2006) (19)
- The isolation of human beta-interferon receptor by wheat germ lectin affinity and immunosorbent column chromatographies. (1986) (19)
- Cardiotoxin‐I: An Unexpectedly Potent Insulinotropic Agent (2012) (19)
- Pituitary adenylate cyclase‐activating polypeptide (PACAP) stimulates the expression and the release of tissue plasminogen activator (tPA) in neuronal cells: involvement of tPA in the neuroprotective effect of PACAP (2011) (19)
- Pituitary adenylate cyclase-activating polypeptide inhibits caspase-3 activity but does not protect cerebellar granule neurons against β-amyloid (25–35)-induced apoptosis (2004) (18)
- Structural characterization and effects on corticosteroid secretion of endothelin-1 and endothelin-3 from the frog Rana ridibunda. (2000) (18)
- Synthesis and biological activity of novel linear and cyclic GRF analogs (1988) (18)
- Effect of the pituitary adenylate cyclase-activating polypeptide on the autophagic activation observed in in vitro and in vivo models of Parkinson's disease. (2016) (18)
- Structural Study of the N‐Terminal Segment of Neuropeptide‐Tyrosine (1990) (17)
- Conformational and biological studies of neuropeptide Y analogs containing structural alterations. (1994) (17)
- Influence of ambient temperature on the effects of NPY on body temperature and food intake (1995) (17)
- Barley serine proteinase inhibitor 2-derived cyclic peptides as potent and selective inhibitors of convertases PC1/3 and furin. (2003) (17)
- Role of the neutral endopeptidase 24.11 in the conversion of big endothelins in guinea‐pig lung parenchyma (1996) (16)
- Development and characterization of a highly selective neuropeptide Y Y5 receptor agonist radioligand: [125I][hPP1–17, Ala31, Aib32]NPY (2003) (16)
- Interaction of benzene 1,2,4-trisphosphate with inositol 1,4,5-trisphosphate receptor and metabolizing enzymes. (1993) (16)
- Aging differentially modifies arterial sensitivity to endothelin-1 and 5-hydroxytryptamine: Studies in dog coronary arteries and rat arterial mesenteric bed (1994) (16)
- Structure of human calcitonin gene-related peptide (hCGRP) and of its antagonist hCGRP 8-37 as determined by NMR and molecular modeling. (1995) (16)
- Effects of calcium antagonists on endothelin‐1‐induced myocardial ischaemia and oedema in the rat (1996) (16)
- Neurochemical Effects of CGRP a (1992) (15)
- Presence of urotensin-II receptors at the cell nucleus: specific tissue distribution and hypoxia-induced modulation. (2012) (15)
- CGRP 8-37 blocks the inhibition of gastric emptying induced by intravenous injection of α-CGRP in rats (1993) (15)
- Structure and in vitro transcription of a glycine tRNA gene from Bombyx mori. (1984) (15)
- Molecular characterization of human and bovine ceruloplasmin using MALDI-TOF mass spectrometry. (2001) (15)
- Induction of serpinb1a by PACAP or NGF is required for PC12 cells survival after serum withdrawal (2014) (15)
- Neuropeptide Y receptor subtypes in the dorsal vagal complex under acute feeding adaptation in the adult rat (2010) (15)
- Biological and molecular analyses of structurally reduced analogues of endothelin-1. (1996) (15)
- Photoreleasable ligands to study intracrine angiotensin II signalling (2015) (15)
- Ontogeny of pituitary adenylate cyclase‐activating polypeptide (PACAP) in the frog (Rana ridibunda) tadpole brain: Immunohistochemical localization and biochemical characterization (2001) (15)
- Involvement of stathmin 1 in the neurotrophic effects of PACAP in PC12 cells (2010) (14)
- Structural comparison of alanine-substituted analogues of the calcitonin gene-related peptide 8-37. Importance of the C-terminal segment for antagonistic activity. (2009) (14)
- Neuropeptide Y inhibits the biosynthesis of sulfated neurosteroids in the hypothalamus through activation of Y(1) receptors. (2002) (14)
- Development of a selective peptide antagonist for the human natriuretic peptide receptor-B (2005) (14)
- Conformational characterization by circular-dichroism spectroscopy of various fragments and analogs of calcitonin-gene-related peptide. (1993) (14)
- Pituitary Adenylate Cyclase-Activating Polypeptide Prevents C 2-Ceramide-Induced Apoptosis of Cerebellar Granule Cells (2003) (14)
- A potent and selective CGRP2 agonist, [Cys(Et)2,7]hCGRP alpha: comparison in prototypical CGRP1 and CGRP2 in vitro bioassays. (1997) (14)
- Bax siRNA promotes survival of cultured and allografted granule cell precursors through blockade of caspase-3 cleavage (2008) (14)
- The stimulatory effect of endothelin-1 on frog adrenocortical cells is mediated through both the phospholipase C and the adenylyl cyclase transduction pathways (1999) (13)
- Use of Adrenomedullin Derivatives for Molecular Imaging of Pulmonary Circulation (2008) (13)
- Neurochemical effects of neuropeptide Y (NPY) and NPY2-36 (1994) (13)
- Involvement of multiple signaling pathways in PACAP-induced EM66 secretion from chromaffin cells (2006) (13)
- Differential transcription of multiple copies of a silk worm gene encoding tRNA(Gly1). (1993) (13)
- Hydrophobic forces are responsible for the folding of a highly potent natriuretic peptide analogue at a membrane mimetic surface: an NMR study. (1997) (13)
- Pharmacological Characterization of the ETA Receptor in the Vascular Smooth Muscle Comparing its Analogous Distribution in the Rat Mesenteric Artery and in the Arterial Mesenteric Bed (1996) (13)
- Effect of endothelin-1 on corticosteroid secretion by the frog adrenal gland is mediated by an endothelinA receptor. (1997) (13)
- Identification of Proteins Regulated by PACAP in PC12 Cells by 2D Gel Electrophoresis Coupled to Mass Spectrometry (2006) (13)
- Structure activity analysis of CGRP's neurobehavioral effects (1991) (13)
- Solution structure of urotensin-II receptor extracellular loop III and characterization of its interaction with urotensin-II (2008) (12)
- D-myo-inositol 1,2,6-trisphosphate blocks neuropeptide Y-induced facilitation of noradrenaline-evoked vasoconstriction of the mesenteric bed. (1993) (12)
- Balanced effect of PACAP and FasL on granule cell death during cerebellar development: a morphological, functional and behavioural characterization (2010) (12)
- Distribution of PACAP Receptor mRNAs and PACAP Binding Sites in the Rat Brain During Development (2000) (12)
- Development and pharmacological characterization of conformationally constrained urotensin II-related peptide agonists. (2013) (12)
- Comparison of PD 145065 and Ro 46-2005 as antagonists of contractions of guinea-pig airways induced by endothelin-1 or IRL 1620. (1994) (12)
- Evaluation of conformational and binding characteristics of various natriuretic peptides and related analogs. (1995) (12)
- Applications of BOP reagent in solid phase synthesis. II: Solid phase side-chain to side-chain cyclizations using BOP reagent (2009) (12)
- The Delayed Rectifier Channel Current IK Plays a Key Role in the Control of Programmed Cell Death by PACAP and Ethanol in Cerebellar Granule Neurons (2006) (12)
- Development and pharmacological characterization of “caged” urotensin II analogs (2005) (12)
- Effects of Pituitary Adenylate Cyclase‐Activating Polypeptide, Vasoactive Intestinal Polypeptide, and Somatostatin on the Release of Thyrotropin from the Bullfrog Pituitary (2006) (12)
- Influence of neuropeptide Y on regional vascular capacitance in dogs. (1994) (11)
- Identification of ETA and ETB binding domains using ET-derived photoprobes. (2008) (11)
- Structural characterizations of neuropeptide tyrosine (NPY) and its agonist analog [Ahx5-17]NPY by NMR and molecular modeling. (2009) (11)
- Rapid degradation of endothelin‐1 by an enzyme released by the rat isolated perfused mesentery (1995) (11)
- Molecular imaging of the human pulmonary vascular endothelium in pulmonary hypertension: a phase II safety and proof of principle trial (2017) (11)
- Rôle neurotrophique potentiel du pituitary adenylate cyclase-activating polypeptide. (1997) (11)
- Ontogeny of PACAP receptors in the human cerebellum: Perspectives of therapeutic applications (2006) (11)
- Endothelin reduces microvascular blood flow by acting on arterioles and venules of the hamster cheek pouch. (1990) (11)
- Effect of starvation on tRNA synthesis, amino acid pool, tRNA charging levels and aminoacyl-tRNA synthetase activities in the posterior silk gland of Bombyx mori L. (1979) (11)
- A role for Na+/H+ exchange in contraction of guinea pig airways by endothelin-1 in vitro. (1991) (11)
- PulmoBind, an Adrenomedullin-Based Molecular Lung Imaging Tool (2013) (11)
- Role of the Cationic C-Terminal Segment of Melittin on Membrane Fragmentation. (2016) (11)
- Expression and processing of the [Pro(2),Met(13)]somatostatin-14 precursor in the intermediate lobe of the frog pituitary. (2002) (10)
- Mechanism of action of endothelins on adrenocortical cells. (1998) (10)
- Design of a truncated cardiotoxin-I analogue with potent insulinotropic activity. (2014) (10)
- Presence of PACAP and PACAP receptors in the human adrenal gland: possible role in fetal development. (1998) (10)
- Molecular Imaging of Monocrotaline-Induced Pulmonary Vascular Disease with Radiolabeled Linear Adrenomedullin (2009) (10)
- PulmoBind Imaging Measures Reduction of Vascular Adrenomedullin Receptor Activity with Lack of effect of Sildenafil in Pulmonary Hypertension (2019) (10)
- Caged ligands to study the role of intracellular GPCRs. (2016) (10)
- Development of natriuretic peptide analogs selective for the atrial natriuretic factor-R1A receptor subtype. (1993) (10)
- In vivo central actions of NPY(1–30), an N-terminal fragment of neuropeptide Y (1994) (10)
- Characterization of the adrenomedullin receptor acting as the target of a new radiopharmaceutical biomolecule for lung imaging. (2009) (9)
- A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals. (1999) (9)
- Contribution of hGH20K variant to blood hGH response in sauna and exercise (2004) (9)
- Role of Extracellular Domain Dimerization in Agonist-Induced Activation of Natriuretic Peptide Receptor A (2008) (9)
- Involvement of the Y2 receptor subtype in the regulation of prolactin gene expression by neuropeptide Y in the male rat (1995) (9)
- New insights about the peculiar role of the 28–38 C‐terminal segment and some selected residues in PACAP for signaling and neuroprotection (2018) (9)
- Inhibitory action of neuropeptide Y on agonist-induced responses in isolated guinea pig trachea. (1992) (9)
- Changes in NPY‐mediated modulation of hippocampal [3H]D‐aspartate outflow in the kindling model of epilepsy (2003) (9)
- Endothelin-1 (ET)-induced mobilization of intracellular Ca2+ stores from the smooth muscle facilitates sympathetic cotransmission by potentiation of adenosine 5′-triphosphate (ATP) motor activity: Studies in the rat vas deferens (1992) (9)
- Neuropeptide Y inhibits spontaneous alpha-melanocyte-stimulating hormone (alpha-MSH) release via a Y(5) receptor and suppresses thyrotropin-releasing hormone-induced alpha-MSH secretion via a Y(1) receptor in frog melanotrope cells. (2002) (9)
- Evidence for the involvement of nitric oxide in the control of steroid secretion by the frog adrenal gland (2001) (8)
- VIP and PACAP analogs regulate therapeutic targets in high-risk neuroblastoma cells (2016) (8)
- Photolabeling study of the ligand binding domain of natriuretic peptide receptor A: development of a model. (2005) (8)
- Activation of PAC1 Receptors in Rat Cerebellar Granule Cells Stimulates Both Calcium Mobilization from Intracellular Stores and Calcium Influx through N-Type Calcium Channels (2013) (8)
- Neurochemical effects of CGRP (1991) (8)
- Structure-activity relationships of ET-1 and selected analogues in the isolated guinea pig trachea: evidence for the existence of different ETB receptor subtypes. (1993) (8)
- Al[18F]F-complexation of DFH17, a NOTA-conjugated adrenomedullin analog, for PET imaging of pulmonary circulation. (2018) (8)
- Transmembrane domain V of the endothelin-A receptor is a binding domain of ETA-selective TTA-386-derived photoprobes. (2005) (7)
- Conformational analysis of biologically active truncated linear analogs of endothelin-1 using NMR and molecular modeling. (1999) (7)
- Inhibitory action of calcitonin gene‐related peptide (CGRP) in the mouse colon (1990) (7)
- Involvement of the Adenylyl Cyclase/Protein Kinase A Signaling Pathway in the Stimulatory Effect of PACAP on Frog Adrenocortical Cells (2006) (7)
- Upregulation of pancreatic polypeptide-sensitive neuropeptide Y (NPY) receptors in estrogen-induced hypertrophy of the anterior pituitary gland in the Fischer-344 rat (2000) (7)
- Design and biological assessment of membrane-tethering neuroprotective peptides derived from the pituitary adenylate cyclase-activating polypeptide type 1 receptor. (2019) (7)
- Pituitary Adenylate Cyclase‐Activating Polypeptide Stimulates Secretoneurin Release and Secretogranin II Gene Transcription in Bovine Adrenochromaffin Cells (2002) (7)
- Synthesis of a hydrophilic affinity matrix for the purification of the vasoactive intestinal peptide receptor. (1993) (7)
- Localization of Pituitary Adenylate Cyclase‐Activating Polypeptide in the Central Nervous System of the European Eel Anguilla anguilla: Stimulatory Effect of PACAP on GH Secretion a (1998) (7)
- Humanβ:α but not γ interferon binding site is a product of the chromosome 21 interferon action gene (1985) (7)
- HGH20k species and variability of GH responses to long-duration exercise in male cyclists fed different food supplements. (1991) (7)
- PACAP Stimulates the Release of the Secretogranin II‐Derived Peptide EM66 from Chromaffin Cells (2006) (6)
- Characterization of iodinated adrenomedullin derivatives suitable for lung nuclear medicine. (2011) (6)
- Novel splice variants of type I pituitary adenylate cyclase-activating polypeptide receptor in frog exhibit altered adenylate cyclase stimulation and differential relative abundance. (2002) (6)
- Molecular, cellular, and functional characterizations of pituitary adenylate cyclase‐activating polypeptide and its receptors in the cerebellum of New and Old World monkeys (2007) (6)
- Evaluation of the contribution of mast cell mediators to the hypotensive activity of various peptides in rats (1983) (6)
- PTHrP fragments 1-16 and 1-23 do not bind to either the ETA or the ETB endothelin receptors (2005) (6)
- Paradoxical effect of ethanol on potassium channel currents and cell survival in cerebellar granule neurons (2009) (6)
- Reversed-phase separation of aminoacyl-transfer RNA's on capillary columns. (1973) (6)
- Structure-activity relationship of analogues of endothelin-1: dissociation of hypotensive and pressor actions. (1992) (6)
- Molecular Cloning, mRNA Distribution and Pharmacological Characterization of a VIP/PACAP Receptor in the Frog Rana ridibunda (2000) (6)
- Identification of a binding domain of the endothelin-B receptor using a selective IRL-1620-derived photoprobe. (2004) (6)
- Differential effects of pertussis toxin on body temperature changes induced by neuropeptide Y and NPY2–36 (1994) (6)
- Characterization of the non‐adrenergic/non‐cholinergic response to perivascular nerve stimulation in the double‐perfused mesenteric bed of the mouse (2007) (6)
- Biochemical Characterization of a Caspase-3 Far-red Fluorescent Probe for Non-invasive Optical Imaging of Neuronal Apoptosis (2014) (6)
- The Pharmacophoric Determinants of PACAP (2016) (5)
- Contractile activity of endothelin precursors in the isolated gallbladder of the guinea‐pig: presence of an endothelin‐converting enzyme (1995) (5)
- Study of solid-phase synthesis and purification strategies for the preparation of polyglutamine peptides. (2007) (5)
- Muscular Neuropeptide Y Receptors Involved in the Potentiation of the Noradrenaline‐Induced Vasoconstriction in Isolated Coronary Arteries a (1990) (5)
- Molecular Imaging of the Human Pulmonary Vascular Endothelium Using an Adrenomedullin Receptor Ligand (2015) (5)
- Development of agonists of endothelin‐1 exhibiting selectivity towards ETA receptors (2003) (5)
- PACAP and Ceramides Exert Opposite Effects on Migration, Neurite Outgrowth, and Cytoskeleton Remodeling (2006) (5)
- Characterization of the Endothelin‐Converting Enzyme in Guinea Pig Upper Bronchus (1995) (5)
- New short peptide substrates of endothelin-converting enzyme and characterization of the enzyme. (2000) (4)
- Starvation-induced alterations of ribosomal protein phosphorylation in Bombyx mori L. Evidence for different phosphorylation kinetics in free and membrane-bound ribosomes. (1987) (4)
- Relaxation by dexamethasone of isolated guinea-pig airways precontracted with endothelin-1. (1993) (4)
- Design and application of light-activated probes for cellular signaling. (2015) (4)
- SAR442085, a novel anti-CD38 antibody with enhanced antitumor activity against multiple myeloma. (2021) (4)
- Synthesis and structure-activity analysis of fragments and analogs of CGRP8–37 (1991) (4)
- Effects of PACAP in the Local Regulation of Endocrine Glands (2006) (4)
- Antagonism of the inhibitory action of neuropeptide Y (NPY) in guinea‐pig trachea by the C‐terminal fragment NPY (2–36) (1993) (4)
- Abstract 2266: SAR442085, a next generation anti-CD38 antibody with enhanced antibody-dependent cellular cytotoxicity (ADCC) against multiple myeloma (2020) (4)
- Synthesis and Structure‐Activity Analysis of Fragments and Analogs of CGRP8‐37 a (1992) (4)
- SIGMA LIGANDS AND NEUROPEPTIDE Y SELECTIVELY POTENTIATE THE NMDA RESPONSE IN THE RAT CA3 DORSAL HIPPOCAMPUS: IN VIVO ELECTROPHYSIOLOGICAL STUDIES. (1992) (4)
- The amidated PACAP1-23 fragment is a potent reduced-size neuroprotective agent. (2019) (4)
- SPECT and PET imaging of adrenomedullin receptors: a promising strategy for studying pulmonary vascular diseases. (2019) (4)
- Evaluation of pulmonary perfusion by SPECT imaging using an endothelial cell tracer in supine humans and dogs (2016) (4)
- 400 MHz NMR study on the C-terminal fragment 21–28 of vasoactive intestinal peptide (1982) (3)
- Functional and Modulated Adaptation of tRNA to Fibroin Biosynthesis in the Silk Gland of Bombyx mori L. (1973) (3)
- Adaptation des tRNA et optimisation de la traduction (1981) (3)
- A Second Somatostatin Gene is Expressed in the Brain of the Frog Rana ridibunda (1998) (3)
- Role of the cytoskeleton in the secretory response of the frog adrenal gland to calcitonin gene-related peptide (1997) (3)
- Evidence for the Differential Distribution of at Least Two Adrenomedullin Receptor Subtypes in the Rat Brain (2001) (3)
- Activation of endothelinA receptors in frog adrenocortical cells stimulates both calcium mobilization from intracellular stores and calcium influx through L-type calcium channels. (2005) (3)
- Endothelin derivatives showing potent effects in the guinea pig trachea (1993) (3)
- PACAP-Derived Carriers: Mechanisms and Applications (2016) (3)
- Optimization of on-resin palladium-catalyzed Sonogashira cross-coupling reaction for peptides and its use in a structure-activity relationship study of a class B GPCR ligand. (2015) (3)
- Pituitary Adenylate Cyclase‐Activating Polypeptide Regulates Neuroendocrine Markers and Transcription Factors in Differentiating Pheochromocytoma Cells (2002) (3)
- Conformational analysis of endothelin-1 analogs with indolizidinone amino acids incorporated at the C-terminus. (2000) (2)
- Lipidated peptides derived from intracellular loops 2 and 3 of the urotensin II receptor act as biased allosteric ligands (2021) (2)
- Functional and modulatory adaptation of tRNA in the silk gland of bombyx mori L. to fibroin biosynthesis. (1973) (2)
- CGRP 8-37[correction of 8-27] blocks the inhibition of gastric emptying induced by intravenous injection of alpha-CGRP in rats. (1993) (2)
- Structure‐Activity Studies of the C‐Terminal Segment of Structurally Reduced Analogues of ET‐1 (1995) (2)
- Pituitary Adenylate Cyclase‐Activating Polypeptide Regulates Both Adrenocortical and Chromaffin Cell Activity in the Frog Adrenal Gland a (1996) (2)
- Effect of Dithiothreitol and Gpp(NH)p on [125I]α‐hCGRP Binding Sites in Brain and Peripheral Tissues (1992) (2)
- Molecular imaging of the human pulmonary vascular endothelium using an adrenomedullin receptor ligand. (2015) (2)
- Sequence of a glutamic acid tRNA gene from Bombyx mori. (1986) (1)
- Evidence for CGRP receptor sub-types using selective agonists and antagonists (1991) (1)
- Ontogeny of the somatostatin variant [Pro2,Met13]somatostatin‐14 in the brain, pituitary, and sensory organs of the frog Rana esculenta (2006) (1)
- Bombyx mori L. Ribosomal proteins: Resolution, nomenclature, molecular weights and in vivo phosphorylation (2004) (1)
- Effect of dithiothreitol and Gpp(NH)p on [125I]hCGRPα binding sites in brain and peripheral tissues (1991) (1)
- The brain galanin receptor: Purification by a one-step affinity chromatography (1993) (1)
- Solid phase peptide synthesis using BOP reagent: Synthesis of growth hormone releasing factor (GRF) analogs (1988) (1)
- Characterization of some neurotrophic activities of PACAP and development of new analogs for in vivo treatments (2010) (1)
- Abstract 2101: Molecular Imaging Of Pulmonary Arterial Hypertension With Radiolabeled Linear Adrenomedullin (2007) (1)
- [tRNA adaptation and the optimization of translation]. (1981) (1)
- Human beta:alpha but not gamma interferon binding site is a product of the chromosome 21 interferon action gene. (1985) (1)
- Expression of the avian gag-myc oncogene in Saccharomyces cerevisiae (1990) (1)
- An improved procedure for the preparation of the endothelin-B-receptor ligand sarafotoxin 6c. (2000) (1)
- Applications of BOP reagent in solid phase peptide synthesis III. Solid phase peptide synthesis with unprotected aliphatic and aromatic hydroxyamino acids using BOP reagent (2009) (1)
- [Effects of PACAP and C2-ceramide on motility of cerebellar granule neurons: the fastest is not the farthest]. (2005) (1)
- Development of p-benzoylbenzoylated [N,C,rANP(1-28)]pBNP32 (pBNP1) derivatives and affinity photolabeling of the bovine NPR-A receptor. (1999) (1)
- The role of the renal prostaglandins and thromboxanes during high sodium/low potassium and low sodium/high potassium: Intake in the mechanism of sodium excretion and the regulation of blood pressure (1984) (1)
- The genetically modified fungal cell, and a method for producing recombinant DNA molecule and DNA fragment, and the use of (1995) (0)
- pituitary adenylate cyclase-activating polypeptide analog displaying potent neuroprotective activity and reduced in vivo cardiovascular side effects in a Parkinson ' s disease model (2015) (0)
- Conformational characterization by circular-dichroism spectroscopy of various fragments and analogs of calcitonin-gene-related peptide. (1994) (0)
- Key role of secondary conformational conversion in glycosaminoglycans-mediated cellular uptake of PACAP , a cationic cell-penetrating peptide (2014) (0)
- Chapter 138 – PACAP (2013) (0)
- Structural characterization and e ff ects on corticosteroid secretion of endothelin-1 and endothelin-3 from the frog Rana ridibunda (2000) (0)
- The modified Kluyveromyces yeasts, their preparation and use, and a method of producing recombinant proteins (1994) (0)
- Modified fungal cells and method for Manufacture of recombinant products (1993) (0)
- PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE, VASOACTIVE INTESTINAL POLYPEPTIDE, AND SOMATOSTATIN INFLUNCE THE RELEASE OF THYROTROPIN FROM THE BULLFROG PITUITARY IN VITRO (2005) (0)
- Double hybrid system on the basis of gene silencing by transcriptional interference (2005) (0)
- SPECT Imaging of Chronic Thromboembolic Pulmonary Hypertension Using a Pulmonary Vascular Endothelium Tracer (2017) (0)
- Process for the preparation of the compositions of biologically active polypeptides and pharmaceutical compositions containing them and to their encoding nucleotide sequences, expression cassettes, plasmids and cells (1994) (0)
- Regulation of neuronal alpha-melanocyte-stimulating hormone by neuropeptide Y. In vitro and in vivo studies. (1993) (0)
- Preparation and characterization of biotinylated probes for the β-interferon receptor (1988) (0)
- Mechanism of Action of Endothelin‐1 in the Frog Adrenal Gland (1998) (0)
- Development of a photolabile ligand for the endothelin-A receptor of endothelin. (2000) (0)
- Pituitary Adenylate Cyclase‐Activating Polypeptide Receptors in the Fetal Human Adrenal Gland a (1998) (0)
- Sequence of a lysine tRNA gene from Bombyx mori. (1986) (0)
- How to improve PACAP efficiency for neuroprotection and neurorepair? (2017) (0)
- Chapter 119 – PACAP (2013) (0)
- Adrenomedullinderivater labeled, and their use for imaging and therapy (2008) (0)
- Identification of Key-Residues of Urotensin II, a Potent Mammalian Vasoconstrictor (2001) (0)
- Compositions used to regulate the activity of parkin. (2001) (0)
- SPECT)ission computed tomography Physiological imaging of the lung (2015) (0)
- Vascular Responses to Endothelin-1 in Conscious Rats: Modulation by Endogenous Nitric Oxide (1995) (0)
- Modified yeast Kluyveromyces their production and use (1993) (0)
- SYNTHESIS OF PEPTIDES BY THE SOLID-PHASE METHOD. 7. SUBSTANCE P AND ANALOGS (1982) (0)
- Pepducin UT-Pep2 a biased allosteric agonist of Urotensin-II receptor (2019) (0)
- Effect of neuropeptide Y on bradykinin-induced release of prostacyclin and thromboxane from guinea pig perfused lung. (1997) (0)
- PulmoBind Imaging Measures Reduction of Vascular Adrenomedullin Receptor Activity with Lack of effect of Sildenafil in Pulmonary Hypertension (2019) (0)
- REVIEW Endothelins as local activators of adrenocortical cells (2004) (0)
- Radiolabeling a novel NOTA-adrenomedullin derivative via the Al18F approach (2016) (0)
- modified Kluyveromyces yeasts, formulation and use. (1993) (0)
- New derived polypeptides of the human JNK3 protein, variants thereof, corresponding nucleotide sequences and their uses (1999) (0)
- two-hybrid system based on the power of silence genes by transcriptional interference (2004) (0)
- Bax gene suppression by RNA interference promotes survival of cerebellar neuronal allografts through blockade of caspase-3 cleavage (2007) (0)
- Isolation, purification and preliminary structural determination of the toxins from scorpion Lychas mucronatus (2014) (0)
- Investigation of the mechanism of sodium excretion in conscious rats: The role of the endogenous prostaglandins and thromboxanes (1984) (0)
- Related Peptide, and Their Receptor: From Structure to Function - International Union of Basic and Clinical Pharmacology. XCII. Urotensin II, Urotensin II (2015) (0)
- Method of protecting recombinant proteins and host cells used. (1992) (0)
- Dealing with the Aggregation Problem of Polyglutamine Peptides: Synthesis Strategies (2006) (0)
- Method for manufacturing recombinant proteins and used for host cells (1992) (0)
- Urotensin receptor (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database (2019) (0)
- FE65 regulates the processing of the amyloid precursor protein (APP) (2000) (0)
- Evaluation of structural modifications in the helical stretch of NPY (1992) (0)
- PAC 1 Receptor Activation by PACAP-38 Mediates Ca 2؉ Release from a cAMP-dependent Pool in Human Fetal Adrenal Gland Chromaffin Cells* Downloaded from (2020) (0)
- [Reactivity of internal mammary artery and saphenous vein used in human myocardial revascularization: studies with endogenous vasoconstrictors and vasodilators]. (1994) (0)
- Polypeptides comprising protein gax domains involved in transcription repression and / or interacting with other proteins, corresponding nucleic acids and uses thereof (1996) (0)
- Neuroendocrine Control of Frog Adrenocortical Cells by Calcitonin Gene‐Related Peptide (1998) (0)
- Serpin b1a controls the antiapoptotic effects of PACAP and NGF in PC12 cells. (2007) (0)
- MOLECULAR IMAGING OF THE HUMAN PULMONARY VASCULAR ENDOTHELIUM IN PULMONARY HYPERTENSION: THE PULMOBIND SAFETY AND PROOF OF PRINCIPLE TRIAL (2016) (0)
- Membrane-tethered peptides derived from intracellular loops 2 and 3 of the urotensin II receptor act as allosteric biased ligands (2020) (0)
- Neurotrophic Activity of Pituitary Adenylate Cyclase‐Activating Polypeptide a (1998) (0)
- Peptides capable of inhibiting the endocytosis of APP sequences and corresponding nucleotide (1995) (0)
- Modified fragments of endothelin active in an ET-A receptor bioassay (2000) (0)
- Abstract 18807: Spatial Distribution of the Metabolically Active Pulmonary Circulation in Humans (2014) (0)
- Discovery of novel bioactive peptides: the uniquely important contribution of amphibians to mammalian neuropeptidology (2007) (0)
- Saccharomyces cerevisiae . US 005646 O 12 A 11 Patent Number : 5 , 646 , 012 45 Date of Patent : Jul . 8 (2017) (0)
- Characterization of CGRP receptor sites in rat airways (1991) (0)
- Neuropeptide Y selectively potentiates the neuronal response to NMDA in the CA3 region of the rat dorsal hippocampus via a subtype of sigma receptors (1993) (0)
- Novel, biologically active polypeptides, their preparation and pharmaceutical composition containing these polypeptides (1993) (0)
- Structure of human CGRP 1–37 and of its antagonist CGRP 8–37 as determined by two-dimensional NMR (1995) (0)
- Characterization of the Modulation of Neuronal Response to NMDA by Neuropeptide Y (1992) (0)
- Modified yeast Kluveromyces their production and use (1993) (0)
- Roleoftheneutral endopeptidase 24.11intheconversion ofbig endothelins inguinea-piglungparenchyma (1996) (0)
- Abstract 13203: Novel Photoreleasable Caged Angiotensin-II Analogs to Study Intracrine Pharmacology in Intact Cells (2013) (0)
- Le pituitary adenylate cyclase-activating polypeptide (PACAP). Partie 1. (2008) (0)
- The new anticoagulant polypeptides, their preparation and pharmaceutical composition containing them (1994) (0)
- Urotensin receptor in GtoPdb v.2021.3 (2021) (0)
- Polypeptides comprising areas of gax protein, involved in transcriptional repression and / or interacting with other proteins, nucleic acids and their corresponding applications (1996) (0)
- Therapeutic activity of pituitary adenylate cyclaseactivating polypeptide (PACAP) in Huntington’s disease (2016) (0)
- Preparation and characterization of biotinylated probes for the beta-interferon receptor. (1988) (0)
- Peptides capables d'inhiber l'endocytose de l'app et sequences nucleotidiques correspondantes (1995) (0)
- Autoradiographic localization of putative CGRP receptor subtypes in rat brain (1991) (0)
- Biochemical Characterization of a Caspase-3 Far-red Fluorescent Probe for Non-invasive Optical Imaging of Neuronal Apoptosis (2014) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Alain Fournier?
Alain Fournier is affiliated with the following schools:
